SBC Medical Group Holdings Inc current report, 31 January 2023

SEC Form 8-K Summary

Business context and reporting period

Registrant: Pono Capital Two, Inc. (Pono), a Delaware special purpose acquisition company. The report concerns events dated January 31, 2023, and was signed February 1, 2023. The filing relates to the proposed business combination with SBC Medical Group Holdings Incorporated (SBC), rather than a periodic financial reporting period.

Transaction and key financial terms

Pono entered into a merger agreement with Pono Two Merger Sub, SBC, Mehana Capital, LLC as purchaser representative, and Yoshiyuki Aikawa as seller representative. Merger Sub is expected to merge with and into SBC, with SBC surviving as a wholly owned subsidiary of Pono following the transaction.

Before closing, SBC will complete restructuring transactions under which SBC Medical Group Co., Ltd., a Japanese corporation, and certain related entities will become subsidiaries of SBC.

The aggregate consideration to SBC security holders is based on a target value of $1.2 billion, subject to adjustments for:

  • The amount by which SBC’s net working capital is below or above $3 million.
  • SBC indebtedness at closing, net of cash.
  • Specified SBC transaction expenses.

The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics for SBC or Pono.

Material changes versus the prior comparable period

No comparable-period financial information or operating results are presented. The material event is the execution of the merger agreement and the planned restructuring of SBC’s Japanese operating entities.

Guidance, outlook, risks, and contingencies

The transaction remains subject to customary closing conditions, including approval by Pono stockholders. The filing states that the transaction may be terminated under specified circumstances and may not be completed on the anticipated timetable or at all.

  • Failure to satisfy closing conditions or obtain stockholder approval.
  • Potential litigation relating to the proposed transaction.
  • Redemptions exceeding anticipated levels or failure to meet Nasdaq initial listing standards.
  • Disruption to SBC’s business relationships, operations, or plans during the transaction.
  • The possible need for additional capital, which may not be available on acceptable terms.
  • Uncertainty regarding the ability to realize the expected benefits of the transaction.
  • Limited useful financial information for estimating future capital expenditures and revenue.
  • Uncertainty regarding SBC’s financial condition, liquidity, results, market opportunity, and the anticipated financial effects of the transaction.

The filing contains forward-looking statements and cautions that actual results may differ materially. It also states that Pono intends to file a proxy statement and related materials with the SEC. The Form 8-K disclosure is furnished under Regulation FD and is not deemed filed for purposes of Section 18 of the Exchange Act.

Investor verification points

  • Review the definitive merger agreement and subsequent proxy statement for final consideration mechanics and closing conditions.
  • Verify SBC’s historical and projected revenue, profitability, cash flow, debt, net working capital, and liquidity when disclosed in later filings.
  • Assess the effect of SBC debt, cash, net working capital, transaction expenses, and shareholder redemptions on the final securities issued.
  • Confirm whether Pono stockholders approve the transaction and whether Nasdaq listing requirements are satisfied.
  • Review subsequent filings for termination rights, litigation, financing needs, restructuring completion, and changes to transaction timing or terms.